Hui-Jen Tsai

10PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersNutrigenomics and personalised nutritionMolecular targetsMolecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 21, 2026
A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC.

|Nov 07, 2025
The Epidemiology of Neuroendocrine Carcinomas in Taiwan: A Population-Based Cancer Registry Study.

Yi-Hsin Yang, Ru-Yu Huang, Pei-Yi Chu

|Aug 20, 2025
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.

Hui-Jen Tsai, Ming-Huang Chen, Hsiu-Po Wang

|Mar 13, 2025
PCK2 promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-β/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination.

Tsung-Ming Chang, Wei-Yu Fang, Hui-Ping Hsu

|Nov 06, 2022
PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation.

Tsung-Ming Chang, Pei-Yi Chu, Hui-You Lin

|Jun 27, 2022
Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway.

Hui-Ping Hsu, Pei-Yi Chu, Tsung-Ming Chang

Pageof 2

Frequent Collaborators

2 joint publications

Jeffrey S Chang

2 joint publications

Li-Tzong Chen

1 joint publications

Ya-Ting Hsu

1 joint publications

Tsai-Yun Chen